Financial writer evaluates BlackBerry's balance sheet, struggles with profitability, and advises caution due to limited ...

This Fool has his eye on these two FTSE 100 stocks. After a strong 2024 so far, he thinks they could continue to climb.

Bristol Myers surges after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter revenue at ...

LONDON ― Britain's new government wants the pensions industry to invest in U.K. plc. Good luck with that. Keir Starmer's fledgling Labour administration has said it will focus on “encouraging” pension ...

Voya Index Solution Portfolios posted positive absolute returns for the period but underperformed their strategic composite benchmarks on a NAV basis. Click to read more.

Data through the week points to a still-resilient economy overall, leaving traders uncertain about the Fed’s next move.

Stock futures were modestly higher ahead of the release of the Federal Reserve's preferred measures of inflation, as major ...

U.S.-listed shares of Chinese firms and China-focused funds jumped on Friday and are set for another day of strong gains, ...

Stock markets in the United Arab Emirates fell on Friday despite China's big stimulus steps as weak oil prices and ongoing ...

U.S.-listed stocks of major Chinese companies were set for further gains on Friday. A combination of easing monetary policy ...

The S&P 500 index recorded impressive gains of 20% so far in 2024 to hit a level of around 5,740 points as of this writing, ...

The stock now trades at a forward P/E of 10 based on the analyst consensus for 2025. With tailwinds from AI demand, the ...